A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis
Overview of attention for article published in American Journal of Obstetrics & Gynecology, March 2018
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (88th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 79 Mendeley